AMAG bails on proxy fight standoff with settlement for 2 board seats

8th October 2019 Uncategorised 0

Amid a proxy fight with activist investor Caligan Partners, AMAG Pharmaceuticals implored shareholders to stay the course on the drugmaker’s strategic vision. With one of its drugs possibly getting pulled from the market, turns out AMAG didn’t intend to stay the course itself.

More: AMAG bails on proxy fight standoff with settlement for 2 board seats
Source: fierce